| Literature DB >> 28861905 |
H A Jinnah1, Alberto Albanese2,3, Kailash P Bhatia4, Francisco Cardoso5, Gustavo Da Prat6,7, Tom J de Koning8, Alberto J Espay9, Victor Fung10, Pedro J Garcia-Ruiz11, Oscar Gershanik12, Joseph Jankovic13, Ryuji Kaji14, Katya Kotschet15, Connie Marras16, Janis M Miyasaki17, Francesca Morgante18, Alexander Munchau19, Pramod Kumar Pal20, Maria C Rodriguez Oroz21,22,23,24, Mayela Rodríguez-Violante25, Ludger Schöls26,27, Maria Stamelou28,29, Marina Tijssen30, Claudia Uribe Roca31, Andres de la Cerda32, Emilia M Gatto33.
Abstract
There are many rare movement disorders, and new ones are described every year. Because they are not well recognized, they often go undiagnosed for long periods of time. However, early diagnosis is becoming increasingly important. Rapid advances in our understanding of the biological mechanisms responsible for many rare disorders have enabled the development of specific treatments for some of them. Well-known historical examples include Wilson disease and dopa-responsive dystonia, for which specific and highly effective treatments have life-altering effects. In recent years, similarly specific and effective treatments have been developed for more than 30 rare inherited movement disorders. These treatments include specific medications, dietary changes, avoidance or management of certain triggers, enzyme replacement therapy, and others. This list of treatable rare movement disorders is likely to grow during the next few years because a number of additional promising treatments are actively being developed or evaluated in clinical trials.Entities:
Keywords: Rare disease; experimental therapeutics; inherited disease; orphan disease; treatment
Mesh:
Year: 2017 PMID: 28861905 PMCID: PMC5921079 DOI: 10.1002/mds.27140
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338